Back to Semaglutide research
semaglutide glp 1 agonist review 2026-04-09 PubMed

Experts Advocate for Better Measurement in Semaglutide Studies for Frail Heart Failure Patients

Reply: Semaglutide in Frail HFpEF: Need for Objective Functional Measures and Body Composition Assessment.

Abstract

Reply: Semaglutide in Frail HFpEF: Need for Objective Functional Measures and Body Composition Assessment. Authors: Pandey A, Kitzman D, Domdey A, Kosiborod M Journal: JACC. Heart failure (2026) DOI: 10.1016/j.jchf.2026.102951

semaglutide glp 1 agonist
Source: pubmed:41951287 · Ingested 2026-04-09 · Digest: gemini-2.5-flash